no more compound tirzepatide Compounded for Weight Loss: What to Know FDA Moves to Permanently Close

A Closer Look at Weight Loss Data Clinical trials have shown promising but varied weight loss outcomes

Most widely known as Ozempic and Wegovy, Semaglutide is a GLP-1 agonist, meaning it mimics the peptide hormone GLP-1

Chromone-derived PDE10 inhibitors (Compound 68 ) show high metabolic stability (rat microsomal, t: 105 min) and strong selectivity, with C-6 substitution improving potency and stability but requiring careful control to avoid solubility loss (Yu et al., 2020)

This isn't just about the numbers in your KLOW dosage guide

In clinical trials, patients using Tirzepatide experienced substantial reductions in body weightoften surpassing the results seen with Semaglutide